Initial treatment for newly diagnosed elderly colorectal cancer patients: Patterns of care in italy and the united states

Journal of the National Cancer Institute - Monographs

Volumn , Issue 46, 2013, Pages 88-98

  Gigli, Anna ^a   Warren, Joan L ^b   Yabroff, K Robin ^b   Francisci, Silvia ^c   Stedman, Margaret ^b   Guzzinati, Stefano ^d   Giusti, Francesco ^e,f   Miccinesi, Guido ^e   Crocetti, Emanuele ^e   Angiolini, Catia ^g   Mariotto, Angela ^b  

^a CNR   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^e Tuscany Cancer Registry   (Italy)

^f Belgian Cancer Registry   (Belgium)

^g Oncology Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER THERAPY; CLINICAL FEATURE; COHORT ANALYSIS; COLON CANCER; COLON SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; ELDERLY CARE; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HOSPITAL CARE; HOSPITAL UTILIZATION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER; RECTUM SURGERY; UNITED STATES; ADJUVANT CHEMOTHERAPY; AGE; CANCER STAGING; COLORECTAL TUMOR; COMPARATIVE STUDY; ECONOMICS; HEALTH CARE COST; MEDICARE; MULTIMODALITY CANCER THERAPY; VERY ELDERLY; COLORECTAL NEOPLASMS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; FEMALE; HEALTH EXPENDITURES; HUMANS; ITALY; MALE; MEDICARE; NEOPLASM STAGING; SEER PROGRAM; UNITED STATES;

EID: 84883008127     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgt006     Document Type: Article

References (30)

1. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12(10):933-980.
2. Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626-633.
3. Schrag D. The price tag on progress-chemotherapy for colorectal cancer. N Engl J Med. 2004;351(4):317-319.
4. Elkin EB, Bach PB. Cancer's next frontier: addressing high and increasing costs. JAMA. 2010;303(11):1086-1087.
5. Warren JL, Barbera L, Bremner KE, et al. End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst. 2011;103(11):853-862.
6. Chung D, Hersey K, Fleshner N. Differences between urologists in United States and Canada in approach to bladder cancer. Urology. 2005;65(5):919-925.
7. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893-1907.
8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
9. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, eds. GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [database online]. Lyon, France: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr. Accessed February 15, 2013.
10. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007;8(9):784-796.
11. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730-756.
12. Gatta G, Capocaccia R, Berrino F, Ruzza MR, Contiero P; EUROPREVAL Working Group. Colon cancer prevalence and estimation of differing care needs of colon cancer patients. Ann Oncol. 2004;15(7):1136-1142.
13. Gatta G, Zigon G, Aareleid T, et al. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study. Acta Oncol. 2010;49(6):776-783.
14. Allemani C, Storm H, Voogd AC, et al. Variation in "standard care" for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer. 2010;46(9):1528-1536.
15. Groome PA, O'Sullivan B, Irish JC, et al. Management and outcome differences in supraglottic cancer between Ontario, Canada, and the Surveillance, Epidemiology, and End Results areas of the United States. J Clin Oncol. 2003;21(3):496-505.
16. Groome PA, O'Sullivan B, Irish JC, et al. Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles? J Clin Epidemiol. 2001;54(3):301-315.
17. Paci E, Crocetti E, Benvenuti A, et al. Tuscany cancer registry. In: Curado MP, Edwards B, Shin HR, et al., eds. Cancer Incidence in Five Continents. Vol. 9. Lyon, France: IARCPress; 2007. IARC Scientific Publications No. 160.
18. Zambon P, Andolfo A, Baracco M, et al. Cancer incidence in Italy, Veneto region (1998-2001. In: Curado MP, Edwards B, Shin HR, et al., eds. Cancer Incidence in Five Continents. Vol. 9. Lyon, France: IARCPress; 2007. IARC Scientific Publications No. 160.
19. World Health Organization. International Classification of Diseases, Ninth Revision, Clinical Modification. Geneva, Switzerland: World Health Organization; 1997.
20. Cislaghi C, Giuliani F. L'Out of Pocket sanitario nelle Regioni Italiane. In: Ancona A, ed. Approfondimenti sull'indagine Multiscopo ISTAT 2005. Roma, Italy: AGENAS; 2008. Monitor No. 22 (suppl 3).
21. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(suppl 8):IV-3-IV-18.
22. American Joint Committee on Cancer. Colon and rectum. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer-Verlag; 2010:143-164.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373-383.
24. Benson AB III, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408-3419.
25. Ederle A, Grazzini G, Senore C. Lo screening dei tumori colorettali in Italia. In: Rosselli Del Turco M, Zappa M, eds. Terzo Rapporto dell'Osservatorio Nazionale per la Prevenzione dei Tumori Femminili, 2004. http://www.osservatorionazionalescreening. it/node/52. Accessed June 5, 2012.
26. Masseria C. Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment. Eur J Health Econ. 2010;10(suppl 1):S41-S49.
27. US Department of Health and Human Services. Cancer Trends Progress Report-2009/2010 Update. http://progressreport.cancer.gov. Accessed June 5, 2012.
28. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264(11):1444-1450.
29. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345(15):1091-1097.
30. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002;20(19):3992-3998.